MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target

por Hung, Chao-Hung, Chiu, Yi-Chun, Chen, Chien-Hung, Hu, Tsung-Hui
Publicado 2014

Serial changes of clinical parameters in a patient with advanced hepatocellular carcinoma with portal vein thrombosis achieving complete response after treatment with sorafenib

por Kee, Kwong-Ming, Hung, Chao-Hung, Wang, Jing-Houng, Lu, Sheng-Nan
Publicado 2014

Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function

por Chien, Tai-Long, Wang, Jing-Houng, Kee, Kwong-Ming, Chen, Chien-Hung, Hung, Chao-Hung, Lu, Sheng-Nan
Publicado 2016

The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals

por Lee, Yu-Chi, Hu, Tsung-Hui, Hung, Chao-Hung, Lu, Sheng-Nan, Chen, Chien-Hung, Wang, Jing-Houng
Publicado 2019

Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment

por Ma, Te-Ling, Hu, Tsung-Hui, Hung, Chao-Hung, Wang, Jing-Houng, Lu, Sheng-Nan, Chen, Chien-Hung
Publicado 2019

Low-dose nivolumab in advanced hepatocellular carcinoma

por Chen, Yen-Hao, Wang, Chih-Chi, Chen, Yen-Yang, Wang, Jing-Houng, Hung, Chao-Hung, Kuo, Yuan-Hung
Publicado 2022

Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma

por Chen, Yen-Hao, Tsai, Ching-Hua, Chen, Yen-Yang, Wang, Chih-Chi, Wang, Jing-Houng, Hung, Chao-Hung, Kuo, Yuan-Hung
Publicado 2023

Peripheral blood toll-like receptor 4 correlates with rapid virological response to pegylated-interferon and ribavirin therapy in hepatitis C genotype 1 patients

por Lee, Chuan-Mo, Hu, Tsung-Hui, Lu, Sheng-Nan, Wang, Jing-Houng, Hung, Chao-Hung, Chen, Chien-Hung, Yen, Yi-Hao
Publicado 2016

Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL

por Yao, Chih-Chien, Hung, Chao-Hung, Hu, Tsung-Hui, Lu, Sheng-Nan, Wang, Jing-Hung, Lee, Chung-Mo, Chen, Chien-Hung
Publicado 2017

Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation

por Chu, Michelle Ong, Shen, Chien-Heng, Chang, Te-Sheng, Xu, Huang-Wei, Yen, Chih-Wei, Lu, Sheng-Nan, Hung, Chao-Hung
Publicado 2018

Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis C

por Yen, Yi-Hao, Kee, Kwong-Ming, Chen, Chien-Hung, Hu, Tsung-Hui, Lu, Sheng-Nan, Wang, Jing-Houng, Hung, Chao-Hung
Publicado 2019

Ultrasound is highly specific in diagnosing compensated cirrhosis in chronic hepatitis C patients in real world clinical practice

por Yen, Yi-Hao, Kuo, Fang-Ying, Chen, Chien-Hung, Hu, Tsung-Hui, Lu, Sheng-Nan, Wang, Jing-Houng, Hung, Chao-Hung
Publicado 2019

Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data

por Yen, Yi-Hao, Chen, Chien-Hung, Hung, Chao-Hung, Wang, Jing-Houng, Lu, Sheng-Nan, Kee, Kwong-Ming, Hu, Tsung-Hui
Publicado 2019

Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection

por Tsai, Ming-Chao, Yen, Yi-Hao, Chang, Kuo-Chin, Hung, Chao-Hung, Chen, Chien-Hung, Lin, Ming-Tsung, Hu, Tsung-Hui
Publicado 2019

Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical Relapse

por Tseng, Tzu-Ning, Kuo, Yuan-Hung, Hu, Tsung-Hui, Hung, Chao-Hung, Wang, Jing-Houng, Lu, Sheng-Nan, Chen, Chien-Hung
Publicado 2022

A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral Therapy

por Chen, Chien-Hung, Hu, Tsung-Hui, Wang, Jing-Houng, Lai, Hsueh-Chou, Hung, Chao-Hung, Lu, Sheng-Nan, Peng, Cheng-Yuan
Publicado 2022

Comparisons of Viral Etiology and Outcomes of Hepatocellular Carcinoma Undergoing Liver Resection between Taiwan and Vietnam

por Nguyen-Dinh, Song-Huy, Li, Wei-Feng, Liu, Yueh-Wei, Wang, Chih-Chi, Chen, Yen-Hao, Wang, Jing-Houng, Hung, Chao-Hung
Publicado 2022

HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral

por Chang, Kuo-Chin, Lin, Ming-Tsung, Wang, Jing-Houng, Hung, Chao-Hung, Chen, Chien-Hung, Chiu, Sherry Yueh-Hsia, Hu, Tsung-Hui
Publicado 2022

Significance of Vitamin D Receptor Gene Polymorphisms for Risk of Hepatocellular Carcinoma in Chronic Hepatitis C

por Hung, Chao-Hung, Chiu, Yi-Chun, Hu, Tsung-Hui, Chen, Chien-Hung, Lu, Sheng-Nan, Huang, Chao-Min, Wang, Jing-Houng, Lee, Chuan-Mo
Publicado 2014

Neutrophil-to-Lymphocyte Ratio as a Predictor of Response to Peginterferon plus Ribavirin Therapy for Chronic Hepatitis C

por Kuo, Ming-Te, Hu, Tsung-Hui, Lu, Sheng-Nan, Hung, Chao Hung, Wang, Jing-Houng, Chen, Chien-Hung, Chiu, Yi-Chun, Lee, Chuan-Mo
Publicado 2014